Quoin Pharmaceuticals Ltd ADR [NASDAQ: QNRX] surged by $3.37 during the normal trading session on Tuesday and reaching a high of $14.0299 during the day while it closed the day at $11.51.
Quoin Pharmaceuticals Ltd ADR stock has also gained 16.73% of its value over the past 7 days. However, QNRX stock has inclined by 60.31% in the 3 months of the year. Over the past six months meanwhile, it has gained 88.07% and lost -54.73% year-on date.
The market cap for QNRX stock reached $6.79 million, with 0.59 million shares outstanding. Compared to the average trading volume of 311.97K shares, QNRX reached a trading volume of 18232415 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Quoin Pharmaceuticals Ltd ADR [QNRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QNRX shares is $47.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QNRX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
QNRX stock trade performance evaluation
Quoin Pharmaceuticals Ltd ADR [QNRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.73. With this latest performance, QNRX shares dropped by -22.54% in over the last four-week period, additionally plugging by 88.07% over the last 6 months – not to mention a drop of -49.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for QNRX stock in for the last two-week period is set at 52.28, with the RSI for the last a single of trading hit 2.25, and the three-weeks RSI is set at 2.18 for Quoin Pharmaceuticals Ltd ADR [QNRX]. The present Moving Average for the last 50 days of trading for this stock 9.93, while it was recorded at 9.38 for the last single week of trading, and 8.96 for the last 200 days.
Quoin Pharmaceuticals Ltd ADR (QNRX) Capital Structure & Debt Analysis
Quoin Pharmaceuticals Ltd ADR (QNRX) Efficiency & Liquidity Metrics
Quoin Pharmaceuticals Ltd ADR (QNRX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Quoin Pharmaceuticals Ltd ADR. (QNRX) effectively leverages its workforce, generating an average of -$2772000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.04% and a Quick Ratio of 1.04%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Quoin Pharmaceuticals Ltd ADR [QNRX] stock
With the latest financial reports released by the company, Quoin Pharmaceuticals Ltd ADR posted -9.73/share EPS, while the average EPS was predicted by analysts to be reported at -15.05/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 5.32. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QNRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Quoin Pharmaceuticals Ltd ADR go to 47.33%.
Quoin Pharmaceuticals Ltd ADR [QNRX]: Institutional Ownership
There are presently around $3.98%, or 4.28%% of QNRX stock, in the hands of institutional investors.
